• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Medical Properties Trust, Inc. Reports Third Quarter Results and Other Updates

    10/30/25 8:00:00 AM ET
    $MPW
    Real Estate Investment Trusts
    Real Estate
    Get the next $MPW alert in real time by email

    Continues Scheduled Increase in Cash Rents from New Operators

    Announces $150 Million Strategic Common Stock Repurchase Program

    Medical Properties Trust, Inc. (the "Company" or "MPT") (NYSE:MPW) today announced financial and operating results for the third quarter ended September 30, 2025, as well as certain events occurring subsequent to quarter end.

    • Net loss of ($0.13) and Normalized Funds from Operations ("NFFO") of $0.13 for the 2025 third quarter on a per share basis. Third quarter net loss includes approximately $82 million ($0.14 per share) in impairment charges primarily related to certain Prospect Medical Group ("Prospect") bankruptcy transactions;
    • Cash rents from MPT's new tenants are fully current through October with the exception of three facilities in Ohio and Pennsylvania (96% of scheduled rents collected). Including approximately $4 million of September rent received on October 1 from a cash-basis tenant, cash collections increased as expected to $16 million in the third quarter versus $11 million in the second quarter; cash collections for the fourth quarter of 2025 (not including the September rent collected on October 1) approximate $22 million;
    • Subsequent to Prospect's August agreement to sell its California operations to NOR Healthcare Systems Corp. ("NOR"), MPT agreed in principle to a lease with NOR which is expected to result in stabilized annual cash rent of $45 million, provided that regulatory approvals are received;
    • Entered into a settlement with Prospect and Yale New Haven Health System ("Yale") in September under which $45 million in cash from Yale, proceeds from the sale of three Connecticut hospitals and other consideration are expected to exceed MPT's current debtor-in-possession ("DIP") loan balance;
    • Sold two facilities in Arizona in August with nominal annual cash rent for approximately $50 million; and
    • Paid a regular quarterly dividend of $0.08 per share in October.

    Edward K. Aldag, Jr., Chairman, President and Chief Executive Officer, said, "Our recently transitioned portfolio continues to ramp cash rents as expected. Following the successful re-tenanting of our California hospitals, we have increased confidence that pro rata annualized cash rent from our current portfolio will exceed $1 billion by the end of 2026."

    The Company also today announced that its board of directors has authorized a program to strategically repurchase up to $150 million of its common stock. Aldag commented, "With cash rents ramping and increased opportunities to turn low-yielding assets into cash, we have growing flexibility to address our near-term debt maturities. With the added expectation for near-term recoveries from Prospect, we feel comfortable with our liquidity and believe strongly that MPT stock is one of the best investments we can make."

    Included in the financial tables accompanying this press release is information about the Company's assets and liabilities, operating results, and reconciliations of net loss to NFFO, including per share amounts, all on a basis comparable to 2024 results.

    PORTFOLIO UPDATE

    Medical Properties Trust has total assets of approximately $14.9 billion, including $9.0 billion of general acute facilities, $2.5 billion of behavioral health facilities and $1.6 billion of post-acute facilities. As of September 30, 2025, MPT's portfolio included 388 properties and approximately 39,000 licensed beds leased to or mortgaged by 51 hospital operating companies across the United States as well as in the United Kingdom, Switzerland, Germany, Spain, Finland, Colombia, Italy and Portugal.

    In Europe, admissions, reimbursement and acuity trends remain strong. Despite an adverse impact on referrals to private behavioral care providers due to recent NHS restructuring in the United Kingdom, Priory's and MPT's overall behavioral health portfolios maintained healthy TTM EBITDARM coverage.

    In the United States, general acute care providers continue to report increasing admissions and TTM EBITDARM coverage year-over-year. In post-acute care settings, operators are driving strong revenue growth while effectively managing contract labor expenses, resulting in a slight year-over-year increase in TTM EBITDARM coverage.

    The new tenants to which MPT has transferred the operations of properties in Florida, Texas, Arizona, and Louisiana continue to report improving performance trends as they ramp up operations. MPT has collected materially all cash rent owed by these tenants through October with the exception of the previously disclosed Ohio facilities, one of which has re-opened with rent expected to resume in 2026, and one open Pennsylvania hospital that owes a nominal amount of rent.

    Prospect's in-court restructuring process which commenced in January 2025 remains underway. In March 2025, the Bankruptcy Court approved a settlement agreement between MPT, Prospect and certain other parties that will enable Prospect to sell its hospital operations and the related real estate with MPT's cooperation. MPT expects NOR's successful bid for Prospect's California operations, which remains subject to regulatory approval, to close by the end of 2025 and result in 50% payments of stabilized annual cash rent of approximately $45 million after a six-month period and full payment of rents at this level after twelve months.

    Further, the Company's settlement with Prospect and Yale related to three Connecticut hospitals, as well as the expected sale of the hospitals (two of which are subject to binding purchase agreements), are expected to result in proceeds exceeding MPT's current DIP loan balance of approximately $100 million. The only remaining potential DIP commitment is a conditional loan of up to $30 million secured by assets including proceeds of causes of action.

    OPERATING RESULTS

    Net loss for the third quarter ended September 30, 2025 was ($78 million) (($0.13) per share), compared to a net loss of ($801 million) (($1.34) per share) in the year earlier period.

    NFFO for the third quarter ended September 30, 2025 was $77 million ($0.13 per share), compared to $94 million ($0.16 per share) in the year-earlier period.

    CONFERENCE CALL AND WEBCAST

    The Company has scheduled a conference call and webcast for October 30, 2025 at 11:00 a.m. Eastern Time to present the Company's financial and operating results for the quarter ended September 30, 2025. The dial-in numbers for the conference call are 800-715-9871 (North America) and 646-307-1963 (International) along with passcode 6695005. The conference call will also be available via webcast in the Investor Relations section of the Company's website, www.medicalpropertiestrust.com.

    A telephone and webcast replay of the call will be available beginning shortly after the call's completion. The telephone replay will be available through November 6, 2025, using dial-in numbers 800-770-2030 (North America) and 609-800-9909 (International) along with passcode 6695005. The webcast replay will be available for one year following the call's completion on the Investor Relations section of the Company's website.

    The Company's supplemental information package for the current period will also be available on the Company's website in the Investor Relations section.

    The Company uses, and intends to continue to use, the Investor Relations page of its website, which can be found at www.medicalpropertiestrust.com, as a means of disclosing material nonpublic information and of complying with its disclosure obligations under Regulation FD, including, without limitation, through the posting of investor presentations that may include material nonpublic information. Accordingly, investors should monitor the Investor Relations page, in addition to following our press releases, SEC filings, public conference calls, presentations and webcasts. The information contained on, or that may be accessed through, our website is not incorporated by reference into, and is not a part of, this document.

    About Medical Properties Trust, Inc.

    Medical Properties Trust, Inc. is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 388 facilities and approximately 39,000 licensed beds in nine countries and across three continents as of September 30, 2025. MPT's financing model facilitates acquisitions and recapitalizations and allows operators of hospitals to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations. For more information, please visit the Company's website at www.medicalpropertiestrust.com.

    Forward-Looking Statements

    This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements can generally be identified by the use of forward-looking words such as "may", "will", "would", "could", "expect", "intend", "plan", "estimate", "target", "anticipate", "believe", "objectives", "outlook", "guidance" or other similar words, and include statements regarding our strategies, objectives, asset sales and other liquidity transactions (including the use of proceeds thereof), expected re-tenanting of facilities and receipt of related rents, expected outcomes from Prospect's Chapter 11 restructuring process and any related transactions, including the application of the Yale settlement payment, the closing of the NOR transaction and receipt of regulatory approvals, and the use of proceeds thereof, MPT's remaining DIP obligations and expected repayments, and potential repurchases under the common stock repurchase program. Forward-looking statements involve known and unknown risks and uncertainties that may cause our actual results or future events to differ materially from those expressed in or underlying such forward-looking statements, including, but not limited to: (i) the risk that projected rents may be lower than anticipated or realized later than expected; (ii) the risk that the NOR transaction will not receive required regulatory approvals for close; (iii) the risk that the timing, outcome and terms of the bankruptcy restructuring of Prospect will not be consistent with those anticipated by the Company; (iv) our success in implementing our business strategy and our ability to identify, underwrite, finance, consummate and integrate acquisitions and investments; (v) the risk that previously announced or contemplated property sales, loan repayments, and other capital recycling transactions do not occur as anticipated or at all; (vi) the risk that MPT is not able to attain its leverage, liquidity and cost of capital objectives within a reasonable time period or at all; (vii) MPT's ability to obtain or modify the terms of debt financing on attractive terms or at all, as a result of changes in interest rates and other factors, which may adversely impact our ability to pay down, refinance, restructure or extend our indebtedness as it becomes due, or pursue acquisition and development opportunities; (viii) the ability of our tenants, operators and borrowers to satisfy their obligations under their respective contractual arrangements with us; (ix) the ability of our tenants and operators to operate profitably and generate positive cash flow, remain solvent, comply with applicable laws, rules and regulations in the operation of our properties, to deliver high-quality services, to attract and retain qualified personnel and to attract patients; (x) the risk that we are unable to monetize our investments in certain tenants at full value within a reasonable time period or at all; (xi) the risk that the operations of our tenants will be negatively impacted by changes to Medicaid funding introduced by the OBBBA; and (xii) the risks and uncertainties of litigation or other regulatory proceedings.

    The risks described above are not exhaustive and additional factors could adversely affect our business and financial performance, including the risk factors discussed under the section captioned "Risk Factors" in our Annual Reports on Form 10-K and our Quarterly Reports on Form 10-Q, and as may be updated in our other filings with the SEC. Forward-looking statements are inherently uncertain and actual performance or outcomes may vary materially from any forward-looking statements and the assumptions on which those statements are based. Readers are cautioned to not place undue reliance on forward-looking statements as predictions of future events. We disclaim any responsibility to update such forward-looking statements, which speak only as of the date on which they were made.

    MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES
     
    Consolidated Balance Sheets
    (Amounts in thousands, except for per share data)
    September 30, 2025 December 31, 2024
    Assets (Unaudited) (A)
    Real estate assets
    Land, buildings and improvements, intangible lease assets, and other

    $

    11,748,943

     

    $

    11,259,842

     

    Investment in financing leases

     

    943,750

     

     

    1,057,770

     

    Real estate held for sale

     

    -

     

     

    34,019

     

    Mortgage loans

     

    127,926

     

     

    119,912

     

    Gross investment in real estate assets

     

    12,820,619

     

     

    12,471,543

     

    Accumulated depreciation and amortization

     

    (1,633,531

    )

     

    (1,422,948

    )

    Net investment in real estate assets

     

    11,187,088

     

     

    11,048,595

     

     
    Cash and cash equivalents

     

    396,577

     

     

    332,335

     

    Interest and rent receivables

     

    25,142

     

     

    36,327

     

    Straight-line rent receivables

     

    851,749

     

     

    700,783

     

    Investments in unconsolidated real estate joint ventures

     

    1,379,600

     

     

    1,156,397

     

    Investments in unconsolidated operating entities

     

    319,192

     

     

    439,578

     

    Other loans

     

    245,535

     

     

    109,175

     

    Other assets

     

    519,312

     

     

    471,404

     

    Total Assets

    $

    14,924,195

     

    $

    14,294,594

     

     
    Liabilities and Equity
    Liabilities
    Debt, net

    $

    9,616,176

     

    $

    8,848,112

     

    Accounts payable and accrued expenses

     

    475,938

     

     

    454,209

     

    Deferred revenue

     

    22,113

     

     

    29,445

     

    Obligations to tenants and other lease liabilities

     

    148,605

     

     

    129,045

     

    Total Liabilities

     

    10,262,832

     

     

    9,460,811

     

     
    Equity
    Preferred stock, $0.001 par value. Authorized 10,000 shares; no shares
    outstanding

     

    -

     

     

    -

     

    Common stock, $0.001 par value. Authorized 750,000 shares; issued and
    outstanding - 601,136 shares at September 30, 2025 and 600,403
    shares at December 31, 2024

     

    601

     

     

    600

     

    Additional paid-in capital

     

    8,602,994

     

     

    8,584,917

     

    Retained deficit

     

    (4,097,973

    )

     

    (3,658,516

    )

    Accumulated other comprehensive income (loss)

     

    154,687

     

     

    (94,272

    )

    Total Medical Properties Trust, Inc. stockholders' equity

     

    4,660,309

     

     

    4,832,729

     

     
    Non-controlling interests

     

    1,054

     

     

    1,054

     

    Total Equity

     

    4,661,363

     

     

    4,833,783

     

    Total Liabilities and Equity

    $

    14,924,195

     

    $

    14,294,594

     

     
    (A) Financials have been derived from the prior year audited financial statements.
    MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES
     
    Consolidated Statements of Income
    (Unaudited)
     
    (Amounts in thousands, except for per share data) For the Three Months Ended For the Nine Months Ended
    September 30, 2025 September 30, 2024 September 30, 2025 September 30, 2024
     
    Revenues
    Rent billed

    $

    181,001

     

    $

    169,721

     

    $

    524,051

     

    $

    552,784

     

    Straight-line rent

     

    36,405

     

     

    36,602

     

     

    116,197

     

     

    119,719

     

    Income from financing leases

     

    9,944

     

     

    9,798

     

     

    29,772

     

     

    53,832

     

    Interest and other income

     

    10,172

     

     

    9,706

     

     

    31,660

     

     

    37,368

     

    Total revenues

     

    237,522

     

     

    225,827

     

     

    701,680

     

     

    763,703

     

     
    Expenses
    Interest

     

    132,395

     

     

    106,243

     

     

    377,905

     

     

    316,358

     

    Real estate depreciation and amortization

     

    66,993

     

     

    204,875

     

     

    198,282

     

     

    382,701

     

    Property-related (A)

     

    8,993

     

     

    4,994

     

     

    26,891

     

     

    17,475

     

    General and administrative

     

    37,734

     

     

    36,625

     

     

    105,842

     

     

    105,300

     

    Total expenses

     

    246,115

     

     

    352,737

     

     

    708,920

     

     

    821,834

     

     
    Other (expense) income
    (Loss) gain on sale of real estate

     

    (9,115

    )

     

    91,795

     

     

    4,156

     

     

    475,196

     

    Real estate and other impairment charges, net

     

    (81,761

    )

     

    (607,922

    )

     

    (159,284

    )

     

    (1,438,429

    )

    Earnings (loss) from equity interests

     

    34,403

     

     

    21,643

     

     

    73,713

     

     

    (369,565

    )

    Debt refinancing and unutilized financing costs

     

    (14

    )

     

    (713

    )

     

    (3,629

    )

     

    (3,677

    )

    Other (including fair value adjustments on securities)

     

    (1,498

    )

     

    (169,790

    )

     

    (171,138

    )

     

    (566,821

    )

    Total other expense

     

    (57,985

    )

     

    (664,987

    )

     

    (256,182

    )

     

    (1,903,296

    )

     
    Loss before income tax

     

    (66,578

    )

     

    (791,897

    )

     

    (263,422

    )

     

    (1,961,427

    )

     
    Income tax expense

     

    (10,872

    )

     

    (9,032

    )

     

    (30,112

    )

     

    (34,538

    )

     
    Net loss

     

    (77,450

    )

     

    (800,929

    )

     

    (293,534

    )

     

    (1,995,965

    )

    Net income attributable to non-controlling interests

     

    (280

    )

     

    (234

    )

     

    (828

    )

     

    (1,458

    )

    Net loss attributable to MPT common stockholders

    $

    (77,730

    )

    $

    (801,163

    )

    $

    (294,362

    )

    $

    (1,997,423

    )

     
    Earnings per common share - basic and diluted:
    Net loss attributable to MPT common stockholders

    $

    (0.13

    )

    $

    (1.34

    )

    $

    (0.49

    )

    $

    (3.33

    )

     
    Weighted average shares outstanding - basic

     

    601,136

     

     

    600,229

     

     

    600,867

     

     

    600,197

     

    Weighted average shares outstanding - diluted

     

    601,136

     

     

    600,229

     

     

    600,867

     

     

    600,197

     

     
    Dividends declared per common share

    $

    0.08

     

    $

    0.08

     

    $

    0.24

     

    $

    0.38

     

     
    (A) Includes $2.3 million and $2.6 million of ground lease and other expenses (such as property taxes and insurance) paid directly by us and reimbursed by our tenants for the three months ended September 30, 2025 and 2024, respectively, and $9.3 million and $9.8 million for the nine months ended September 30, 2025 and 2024, respectively.
    MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES
     
    Reconciliation of Net Loss to Funds From Operations
    (Unaudited)
     
    (Amounts in thousands, except for per share data) For the Three Months Ended For the Nine Months Ended
    September 30, 2025 September 30, 2024 September 30, 2025 September 30, 2024
     
    FFO information:
    Net loss attributable to MPT common stockholders

    $

    (77,730

    )

    $

    (801,163

    )

    $

    (294,362

    )

    $

    (1,997,423

    )

    Participating securities' share in earnings

     

    (256

    )

     

    (153

    )

     

    (597

    )

     

    (807

    )

    Net loss, less participating securities' share in earnings

    $

    (77,986

    )

    $

    (801,316

    )

    $

    (294,959

    )

    $

    (1,998,230

    )

     
    Depreciation and amortization

     

    82,242

     

     

    218,646

     

     

    240,465

     

     

    430,128

     

    Loss (gain) on sale of real estate

     

    9,115

     

     

    (91,795

    )

     

    (4,156

    )

     

    (475,196

    )

    Real estate impairment charges

     

    78,677

     

     

    179,952

     

     

    126,645

     

     

    679,276

     

    Funds from operations

    $

    92,048

     

    $

    (494,513

    )

    $

    67,995

     

    $

    (1,364,022

    )

     
    Other impairment charges, net

     

    6,976

     

     

    427,811

     

     

    40,487

     

     

    1,172,789

     

    Litigation, bankruptcy and other (recoveries) costs

     

    (1,125

    )

     

    28,899

     

     

    11,078

     

     

    46,507

     

    Share-based compensation (fair value adjustments) (A)

     

    3,457

     

     

    -

     

     

    3,444

     

     

    -

     

    Non-cash fair value adjustments

     

    (12,066

    )

     

    130,949

     

     

    123,370

     

     

    511,472

     

    Tax rate changes and other

     

    (12,091

    )

     

    8

     

     

    (10,970

    )

     

    4,596

     

    Debt refinancing and unutilized financing costs

     

    14

     

     

    713

     

     

    4,273

     

     

    3,677

     

    Normalized funds from operations

    $

    77,213

     

    $

    93,867

     

    $

    239,677

     

    $

    375,019

     

     
    Certain non-cash and related recovery information:
    Share-based compensation (A)

    $

    8,885

     

    $

    14,427

     

    $

    27,420

     

    $

    30,581

     

    Debt costs amortization

    $

    7,445

     

    $

    4,994

     

    $

    20,435

     

    $

    14,769

     

    Non-cash rent and interest revenue (B)

    $

    349

     

    $

    -

     

    $

    349

     

    $

    -

     

    Cash recoveries of non-cash rent and interest revenue (C)

    $

    556

     

    $

    552

     

    $

    1,620

     

    $

    6,840

     

    Straight-line rent revenue from operating and finance leases

    $

    (39,688

    )

    $

    (41,363

    )

    $

    (124,945

    )

    $

    (129,395

    )

     
     
    Per diluted share data:
    Net loss, less participating securities' share in earnings

    $

    (0.13

    )

    $

    (1.34

    )

    $

    (0.49

    )

    $

    (3.33

    )

    Depreciation and amortization

     

    0.14

     

     

    0.37

     

     

    0.40

     

     

    0.72

     

    Loss (gain) on sale of real estate

     

    0.01

     

     

    (0.15

    )

     

    (0.01

    )

     

    (0.79

    )

    Real estate impairment charges

     

    0.13

     

     

    0.30

     

     

    0.21

     

     

    1.13

     

    Funds from operations

    $

    0.15

     

    $

    (0.82

    )

    $

    0.11

     

    $

    (2.27

    )

     
    Other impairment charges, net

     

    0.01

     

     

    0.71

     

     

    0.06

     

     

    1.94

     

    Litigation, bankruptcy and other (recoveries) costs

     

    -

     

     

    0.05

     

     

    0.02

     

     

    0.08

     

    Share-based compensation (fair value adjustments) (A)

     

    0.01

     

     

    -

     

     

    0.01

     

     

    -

     

    Non-cash fair value adjustments

     

    (0.02

    )

     

    0.22

     

     

    0.21

     

     

    0.85

     

    Tax rate changes and other

     

    (0.02

    )

     

    -

     

     

    (0.02

    )

     

    0.01

     

    Debt refinancing and unutilized financing costs

     

    -

     

     

    -

     

     

    0.01

     

     

    0.01

     

    Normalized funds from operations

    $

    0.13

     

    $

    0.16

     

    $

    0.40

     

    $

    0.62

     

     
    Certain non-cash and related recovery information:
    Share-based compensation (A)

    $

    0.01

     

    $

    0.02

     

    $

    0.05

     

    $

    0.05

     

    Debt costs amortization

    $

    0.01

     

    $

    0.01

     

    $

    0.03

     

    $

    0.02

     

    Non-cash rent and interest revenue (B)

    $

    -

     

    $

    -

     

    $

    -

     

    $

    -

     

    Cash recoveries of non-cash rent and interest revenue (C)

    $

    -

     

    $

    -

     

    $

    -

     

    $

    0.01

     

    Straight-line rent revenue from operating and finance leases

    $

    (0.07

    )

    $

    (0.07

    )

    $

    (0.21

    )

    $

    (0.22

    )

     

    Notes:

     

    Investors and analysts following the real estate industry utilize funds from operations ("FFO") as a supplemental performance measure. FFO, reflecting the assumption that real estate asset values rise or fall with market conditions, principally adjusts for the effects of GAAP depreciation and amortization of real estate assets, which assumes that the value of real estate diminishes predictably over time. We compute FFO in accordance with the definition provided by the National Association of Real Estate Investment Trusts, or Nareit, which represents net income (loss) (computed in accordance with GAAP), excluding gains (losses) on sales of real estate and impairment charges on real estate assets, plus real estate depreciation and amortization, including amortization related to in-place lease intangibles, and after adjustments for unconsolidated partnerships and joint ventures.

     

    In addition to presenting FFO in accordance with the Nareit definition, we disclose normalized FFO, which adjusts FFO for items that relate to unanticipated or non-core events or activities or accounting changes that, if not noted, would make comparison to prior period results and market expectations less meaningful to investors and analysts. We believe that the use of FFO, combined with the required GAAP presentations, improves the understanding of our operating results among investors and the use of normalized FFO makes comparisons of our operating results with prior periods and other companies more meaningful. While FFO and normalized FFO are relevant and widely used supplemental measures of operating and financial performance of REITs, they should not be viewed as a substitute measure of our operating performance since the measures do not reflect either depreciation and amortization costs or the level of capital expenditures and leasing costs (if any not paid by our tenants) to maintain the operating performance of our properties, which can be significant economic costs that could materially impact our results of operations. FFO and normalized FFO should not be considered an alternative to net income (loss) (computed in accordance with GAAP) as indicators of our results of operations or to cash flow from operating activities (computed in accordance with GAAP) as an indicator of our liquidity.

     

    Certain line items above (such as depreciation and amortization) include our share of such income/expense from unconsolidated joint ventures. These amounts are included with all activity of our equity interests in the "Earnings (loss) from equity interests" line on the consolidated statements of income.

     

    (A) Total share-based compensation expense is $12.3 million and $30.9 million for the three and nine months ended September 30, 2025, respectively, (including certain awards that are to be settled in cash). Cash-settled awards are typically recorded in accordance with GAAP at fair value and measured at each balance sheet date until settlement. The resulting fluctuations, which are primarily driven by changes in our stock price rather than operational performance, can introduce significant volatility in our earnings. To enhance comparability and provide a more stable view of performance over time, NFFO reflects a $3.5 million and $3.4 million adjustment in the three and nine months ended September 30, 2025, respectively, to arrive at total share-based compensation expense using grant date fair value for all awards (including cash-settled awards) of $8.9 million and $27.4 million for the three and nine months ended September 30, 2025.

     

    (B) Includes revenue accrued during the period but not received in cash, such as deferred rent, payment-in-kind ("PIK") interest or other accruals.

     

    (C) Includes cash received to satisfy previously accrued non-cash revenue, such as the cash receipt of previously deferred rent or PIK interest.

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20251029177399/en/

    Drew Babin, CFA, CMA

    Head of Financial Strategy and Investor Relations

    Medical Properties Trust, Inc.

    (646) 884-9809

    [email protected]

    Get the next $MPW alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $MPW

    DatePrice TargetRatingAnalyst
    3/12/2025$5.00 → $9.00Neutral → Outperform
    Exane BNP Paribas
    9/13/2024$6.50Neutral → Buy
    Colliers Securities
    7/2/2024$4.00Outperform → Neutral
    Exane BNP Paribas
    4/17/2024$5.00Sell → Hold
    Deutsche Bank
    4/10/2024$10.00 → $4.25Buy → Neutral
    Colliers Securities
    3/1/2024$6.00Neutral → Outperform
    Exane BNP Paribas
    1/30/2024$2.00Sell
    Deutsche Bank
    1/5/2024Overweight → Sector Weight
    KeyBanc Capital Markets
    More analyst ratings

    $MPW
    SEC Filings

    View All

    SEC Form 8-K filed by Medical Properties Trust Inc.

    8-K - MEDICAL PROPERTIES TRUST INC (0001287865) (Filer)

    10/30/25 8:36:14 AM ET
    $MPW
    Real Estate Investment Trusts
    Real Estate

    SEC Form 424B5 filed by Medical Properties Trust Inc.

    424B5 - MEDICAL PROPERTIES TRUST INC (0001287865) (Filer)

    8/11/25 5:30:18 PM ET
    $MPW
    Real Estate Investment Trusts
    Real Estate

    SEC Form 8-K filed by Medical Properties Trust Inc.

    8-K - MEDICAL PROPERTIES TRUST INC (0001287865) (Filer)

    7/31/25 8:30:46 AM ET
    $MPW
    Real Estate Investment Trusts
    Real Estate

    $MPW
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Medical Properties Trust, Inc. Reports Third Quarter Results and Other Updates

    Continues Scheduled Increase in Cash Rents from New Operators Announces $150 Million Strategic Common Stock Repurchase Program Medical Properties Trust, Inc. (the "Company" or "MPT") (NYSE:MPW) today announced financial and operating results for the third quarter ended September 30, 2025, as well as certain events occurring subsequent to quarter end. Net loss of ($0.13) and Normalized Funds from Operations ("NFFO") of $0.13 for the 2025 third quarter on a per share basis. Third quarter net loss includes approximately $82 million ($0.14 per share) in impairment charges primarily related to certain Prospect Medical Group ("Prospect") bankruptcy transactions; Cash rents from MPT's ne

    10/30/25 8:00:00 AM ET
    $MPW
    Real Estate Investment Trusts
    Real Estate

    Medical Properties Trust Announces Third Quarter 2025 Financial Results Conference Call and Webcast

    Medical Properties Trust, Inc. (the "Company" or "MPT") (NYSE:MPW) today announced it will host a conference call and webcast on Thursday, October 30, 2025, at 11:00 a.m. Eastern Time to discuss the company's third quarter 2025 financial results. A press release with third quarter 2025 financial results will be issued before the market opens on October 30, 2025. The dial-in numbers for the conference call are 800-715-9871 (North America) and 646-307-1963 (International) and the passcode is 6695005 to join the conference. Call participants are encouraged to dial in 10-15 minutes early to ensure registration is completed prior to the start of the conference. The conference call will also be

    10/23/25 4:15:00 PM ET
    $MPW
    Real Estate Investment Trusts
    Real Estate

    Medical Properties Trust, Inc. Provides Portfolio Update

    $45 Million Yale Settlement Payment and Additional Sale Proceeds Expected to Significantly Reduce Prospect DIP Loan Sold Two Facilities in Arizona to Current Operator for ~$50 million Medical Properties Trust, Inc. (the "Company" or "MPT") (NYSE: MPW) today provided updates with respect to certain hospitals currently leased to Prospect Medical Holdings ("Prospect") as well as recent asset sales. Yale New Haven Health System ("Yale") has entered into a settlement agreement with Prospect and MPT under which Yale will pay $45 million to Prospect, while Prospect and MPT will release Yale of any obligation to purchase the three facilities in Connecticut that it agreed to purchase in 2022.

    9/29/25 8:00:00 AM ET
    $MPW
    Real Estate Investment Trusts
    Real Estate

    $MPW
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chairman, President & CEO Aldag Edward K Jr covered exercise/tax liability with 80,644 shares, decreasing direct ownership by 2% to 5,274,012 units (SEC Form 4)

    4 - MEDICAL PROPERTIES TRUST INC (0001287865) (Issuer)

    10/7/25 7:00:10 PM ET
    $MPW
    Real Estate Investment Trusts
    Real Estate

    SVP, Senior Advisor to the CEO Portal Larry H covered exercise/tax liability with 6,956 shares, decreasing direct ownership by 1% to 481,691 units (SEC Form 4)

    4 - MEDICAL PROPERTIES TRUST INC (0001287865) (Issuer)

    10/7/25 7:00:09 PM ET
    $MPW
    Real Estate Investment Trusts
    Real Estate

    Senior VP, Controller & CAO Hanna James Kevin covered exercise/tax liability with 5,663 shares, decreasing direct ownership by 1% to 443,568 units (SEC Form 4)

    4 - MEDICAL PROPERTIES TRUST INC (0001287865) (Issuer)

    10/7/25 7:00:07 PM ET
    $MPW
    Real Estate Investment Trusts
    Real Estate

    $MPW
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    $MPW
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Medical Properties Trust upgraded by Exane BNP Paribas with a new price target

    Exane BNP Paribas upgraded Medical Properties Trust from Neutral to Outperform and set a new price target of $9.00 from $5.00 previously

    3/12/25 7:29:27 AM ET
    $MPW
    Real Estate Investment Trusts
    Real Estate

    Medical Properties Trust upgraded by Colliers Securities with a new price target

    Colliers Securities upgraded Medical Properties Trust from Neutral to Buy and set a new price target of $6.50

    9/13/24 7:35:27 AM ET
    $MPW
    Real Estate Investment Trusts
    Real Estate

    Medical Properties Trust downgraded by Exane BNP Paribas with a new price target

    Exane BNP Paribas downgraded Medical Properties Trust from Outperform to Neutral and set a new price target of $4.00

    7/2/24 7:49:27 AM ET
    $MPW
    Real Estate Investment Trusts
    Real Estate

    Senior VP, Controller & CAO Hanna James Kevin bought $42,613 worth of shares (7,411 units at $5.75), increasing direct ownership by 2% to 372,338 units (SEC Form 4)

    4 - MEDICAL PROPERTIES TRUST INC (0001287865) (Issuer)

    3/6/25 4:37:27 PM ET
    $MPW
    Real Estate Investment Trusts
    Real Estate

    Director Pitman Elizabeth N bought $48,603 worth of shares (8,087 units at $6.01), increasing direct ownership by 12% to 76,740 units (SEC Form 4)

    4 - MEDICAL PROPERTIES TRUST INC (0001287865) (Issuer)

    9/19/24 6:01:37 PM ET
    $MPW
    Real Estate Investment Trusts
    Real Estate

    $MPW
    Leadership Updates

    Live Leadership Updates

    View All

    Super Micro Computer and Deckers Outdoor Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600

    NEW YORK, March 1, 2024 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P 100, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, March 18, to coincide with the quarterly rebalance. The changes ensure each index is more representative of its market capitalization range. All companies being added to the S&P 500 are more representative of the large-cap market space, all companies being added to the S&P MidCap 400 are more representative of the mid-cap market space, and all companies being added to the S&P SmallCap 600 are more representative of the small-cap market space. The companies being removed

    3/1/24 6:47:00 PM ET
    $AIT
    $AL
    $APPS
    Industrial Specialties
    Consumer Discretionary
    Diversified Commercial Services
    Multi-Sector Companies

    Medical Properties Trust, Inc.: Please contact the Portnoy Law Firm to recover your losses; November 28, 2023 deadline

    Investors can contact the law firm at no cost to learn more about recovering their losses ​LOS ANGELES, Nov. 13, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Medical Properties Trust, Inc. ("MPW" or the "Company") (NYSE:MPW) investors that a lawsuit filed on behalf of investors that purchased MPW during the class period. Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 844-767-8529 or email: [email protected], to discuss their legal rights, or click here to join the case via www.portnoylaw.com. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors' options for pursuing claims to recover their losses. In May 2023

    11/13/23 7:04:19 PM ET
    $MPW
    Real Estate Investment Trusts
    Real Estate

    Medical Properties Trust, Inc.: Please contact the Portnoy Law Firm to recover your losses; November 28, 2023 deadline

    Investors can contact the law firm at no cost to learn more about recovering their losses ​LOS ANGELES, Oct. 25, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Medical Properties Trust, Inc. ("MPW" or the "Company") (NYSE:MPW) investors that a lawsuit filed on behalf of investors that purchased MPW during the class period. Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 844-767-8529 or email: [email protected], to discuss their legal rights, or click here to join the case via www.portnoylaw.com. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors' options for pursuing claims to recover their losses. In May 2023, MPW,

    10/25/23 5:36:30 PM ET
    $MPW
    Real Estate Investment Trusts
    Real Estate

    $MPW
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Medical Properties Trust Inc.

    SC 13G - MEDICAL PROPERTIES TRUST INC (0001287865) (Subject)

    10/24/24 11:30:20 AM ET
    $MPW
    Real Estate Investment Trusts
    Real Estate

    SEC Form SC 13G/A filed by Medical Properties Trust Inc. (Amendment)

    SC 13G/A - MEDICAL PROPERTIES TRUST INC (0001287865) (Subject)

    1/30/24 11:16:19 AM ET
    $MPW
    Real Estate Investment Trusts
    Real Estate

    SEC Form SC 13G/A filed by Medical Properties Trust Inc. (Amendment)

    SC 13G/A - MEDICAL PROPERTIES TRUST INC (0001287865) (Subject)

    2/3/23 12:23:07 PM ET
    $MPW
    Real Estate Investment Trusts
    Real Estate

    $MPW
    Financials

    Live finance-specific insights

    View All

    Medical Properties Trust, Inc. Reports Third Quarter Results and Other Updates

    Continues Scheduled Increase in Cash Rents from New Operators Announces $150 Million Strategic Common Stock Repurchase Program Medical Properties Trust, Inc. (the "Company" or "MPT") (NYSE:MPW) today announced financial and operating results for the third quarter ended September 30, 2025, as well as certain events occurring subsequent to quarter end. Net loss of ($0.13) and Normalized Funds from Operations ("NFFO") of $0.13 for the 2025 third quarter on a per share basis. Third quarter net loss includes approximately $82 million ($0.14 per share) in impairment charges primarily related to certain Prospect Medical Group ("Prospect") bankruptcy transactions; Cash rents from MPT's ne

    10/30/25 8:00:00 AM ET
    $MPW
    Real Estate Investment Trusts
    Real Estate

    Medical Properties Trust Announces Third Quarter 2025 Financial Results Conference Call and Webcast

    Medical Properties Trust, Inc. (the "Company" or "MPT") (NYSE:MPW) today announced it will host a conference call and webcast on Thursday, October 30, 2025, at 11:00 a.m. Eastern Time to discuss the company's third quarter 2025 financial results. A press release with third quarter 2025 financial results will be issued before the market opens on October 30, 2025. The dial-in numbers for the conference call are 800-715-9871 (North America) and 646-307-1963 (International) and the passcode is 6695005 to join the conference. Call participants are encouraged to dial in 10-15 minutes early to ensure registration is completed prior to the start of the conference. The conference call will also be

    10/23/25 4:15:00 PM ET
    $MPW
    Real Estate Investment Trusts
    Real Estate

    Medical Properties Trust Declares Regular Quarterly Dividend

    Medical Properties Trust, Inc. (the "Company" or "MPT") (NYSE:MPW) today announced that its Board of Directors declared a regular quarterly cash dividend of $0.08 per share of common stock to be paid on October 9, 2025, to stockholders of record on September 11, 2025. About Medical Properties Trust, Inc. Medical Properties Trust, Inc. is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospitals with 392 facilities and approximately 39,000 licensed beds in nine countries and across three continents as of June 30,

    8/14/25 4:55:00 PM ET
    $MPW
    Real Estate Investment Trusts
    Real Estate